NewEdge Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD
MarketBeat
NewEdge Advisors LLC increased its stake in Gilead Sciences, Inc. (NASDAQ:GILD) by 12.7% during the second quarter, bringing its total holdings to 442,389 shares valued at $55.9 million. Institutional investors now own 83.67% of the company's stock, which has a "Moderate Buy" consensus rating and an average price target of $158.04. Despite recent insider selling, Gilead reported strong quarterly revenue and announced a quarterly dividend of $0.82 per share.
Read the full story
This is a short summary. The complete article is published by MarketBeat.
Headline and summary aggregated from public news feeds. For information only — not financial advice.